Fatal hepatitis B reactivation treated with entecavir in an isolated anti-HBs positive lymphoma patient: a case report and literature review (Q36133281)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Fatal hepatitis B reactivation treated with entecavir in an isolated anti-HBs positive lymphoma patient: a case report and literature review	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1 reference

26 October 2022

1 reference

PubMed publication ID

Fatal hepatitis B reactivation treated with entecavir in an isolated anti-HBs positive lymphoma patient: a case report and literature review (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1 reference

27 October 2020

diffuse large B-cell lymphoma

1 reference

27 October 2020

Hepatitis B virus

1 reference

3 November 2019

antiviral agent

1 reference

27 October 2020

1 reference

based on heuristic

inferred from abstract

1 reference

PubMed publication ID

release from viral latency

1 reference

PubMed publication ID

Joana Carvalheiro

2

object named as

Joana Carvalheiro

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1

object named as

Rosa Ferreira

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Sílvia Giestas

5

object named as

Sílvia Giestas

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

6

object named as

Sofia Mendes

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

3

object named as

Joana Torres

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Cláudia Agostinho

7

object named as

Cláudia Agostinho

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

author name string

Alexandra Fernandes

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Mário J Campos

8

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 July 2012

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Saudi Journal of Gastroenterology

9 references

Europe PubMed Central

PMC publication ID

12 August 2017

23 March 2019

21 March 2019

3 April 2019

22 June 2019

3 November 2019

27 October 2020

25 October 2022

26 October 2022

18

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

277-281

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

copyright license

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

8 references

Europe PubMed Central

23 March 2019

Europe PubMed Central

21 March 2019

Europe PubMed Central

3 April 2019

Europe PubMed Central

22 June 2019

Europe PubMed Central

3 November 2019

Europe PubMed Central

27 October 2020

Europe PubMed Central

25 October 2022

Europe PubMed Central

26 October 2022

copyright status

0 references

on focus list of Wikimedia project

0 references

Rituximab Administration and Reactivation of HBV

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409890

2 October 2017

Chronic hepatitis B: update 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409890

2 October 2017

Hepatitis B virus reactivation in a surface antigen-negative and antibody-positive patient after rituximab plus CHOP chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409890

2 October 2017

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409890

2 October 2017

Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409890

2 October 2017

Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409890

2 October 2017

Prospective Analysis of Hepatitis B Virus Reactivation in Patients With Diffuse Large B-Cell Lymphoma After Rituximab Combination Chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409890

23 September 2018

Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409890

23 September 2018

Hepatitis B virus reactivation after 23 months of rituximab-based chemotherapy in an HBsAg-negative, anti-HBs-positive patient with follicular lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409890

23 September 2018

Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409890

23 September 2018

Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409890

23 September 2018

Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409890

23 September 2018

Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409890

23 September 2018

Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409890

23 September 2018

HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409890

23 September 2018

Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409890

23 September 2018

Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3409890

23 September 2018

Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22824772

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab

1 reference

https://pubmed.ncbi.nlm.nih.gov/22824772

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4103/1319-3767.98436

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36133281&oldid=1987992088"